A Christmas Message to the DEA’s Diversion Anti Marijuana Cabal 
89bio Presents Additional Analysis of Phase 1b/2a NASH Study at the Annual ENDO 2021 Conference
New analysis shows BIO89-100 meaningfully reduces liver fat volume and liver volume in patients with NASHSAN FRANCISCO, March 20, 2021...
Rhythm Pharmaceuticals Presents New Data from Phase 2 Basket Study Showing Continued Weight Loss at Up to Nine Months in Patients with HET Obesity on Setmelanotide at ENDO 2021
-- Responders with HET obesity achieved mean weight loss of greater than 12 percent at nine months on setmelanotide therapy...
BridgeBio Pharma Announces Proof-of-Concept Data of Encaleret in ADH1 at the Endocrine Society’s 2021 Annual Meeting
Figure 1 Baseline and Day 5 blood and urine calcium levels – Normalization of Blood Calcium and Urine Calcium in...
Theratechnologies Announces New Data Demonstrating Tesamorelin’s Positive Effect on Immune Response Linked to Liver Inflammation
Data presented at ENDO 2021MONTREAL, March 20, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical...
Chiasma Presents New Positive Data for MYCAPSSA from Phase 3 Trial MPOWERED™ for the Maintenance Treatment of Acromegaly at ENDO 2021
--Data supports MYCAPSSA® as non-inferior to long-acting injectable somatostatin receptor ligands (iSRLs)-- --Data demonstrated patients taking MYCAPSSA had significant improvement...
Data Presented at ENDO 2021 Differentiate LUM-201 from Standard Growth Hormone Secretagogues and Further Support LUM-201’s Potential as a Therapeutic for Pediatric Growth Hormone Deficiency
Data show greater GH response in pediatric growth hormone deficiency (PGHD) from LUM-201 than standard GH secretagoguesAUSTIN, Texas, March 20,...
Strongbridge Biopharma plc Presents Detailed Results from Pivotal Phase 3 LOGICS Study of RECORLEV® (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome at the 2021 Annual Meeting of the Endocrine Society (ENDO)
~ As Previously Reported, LOGICS Met its Primary Endpoint with Statistical Significance ~ ~ Strongbridge Recently Submitted a New Drug...
Hypnotherapy Healing Dubai Relationship Coaching Anxiety Trauma Therapy Launched
A new hypnotherapy healing service in Dubai has been launched by Heart Wisdom Process. It is an unique Eastern holistic...
Starscope Monocular Reviews V2 – Upgrade hit the market – Product Review by Mike Vaughn
StarScope Monocular is an optical tool designed to enable you to use it to capture pictures from miles and depths...
BioSyent Announces Grant of Restricted Share Units
MISSISSAUGA, Ontario, March 19, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent” or the “Company”, TSX Venture: RX) announces that its...
Judgment of the Paris Commercial Court of March 16, 2021 in the case of Biophytis Against Negma Group Ltd
PARIS and CAMBRIDGE, Mass., March 19, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or...
Galapagos increases share capital through subscription right exercises
Mechelen, Belgium; 19 March 2021, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital...
UPDATE: NeuroRx Announces Dosing of First Patient with ZYESAMI™ in P2/3 Clinical Study for the Treatment of Moderate and Severe COVID-19 (AVICOVID-2)
RADNOR, Pa., March 19, 2021 (GLOBE NEWSWIRE) -- NeuroRx, Inc. announced the first patient in its P2/3 study of inhaled...
Kinnate Biopharma Inc. Announces Its Addition to the Russell 2000® Index
SAN FRANCISCO and SAN DIEGO, March 19, 2021 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company...
I-Mab Files Prospectus Supplement for Shelf Registration for Hillhouse
SHANGHAI, China and GAITHERSBURG, Md., March 19, 2021 (GLOBE NEWSWIRE) -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical...
Applied Molecular Transport Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Successfully initiated four planned Phase 2 trials for oral AMT-101 with enrollment ongoing Company on track to announce oral AMT-101...
Electromedical Technologies, Inc. Issues Statement on Recently Identified Promotional Activity Concerning its Common Stock
SCOTTSDALE, Ariz., March 19, 2021 (GLOBE NEWSWIRE) -- ELECTROMEDICAL TECHNOLOGIES, INC. (OTCQB: EMED), a pioneer in the development and manufacturing...
BESLER Receives HFMA Peer Review Designation for Revenue Integrity Solutions
CHICAGO, March 19, 2021 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) recently reviewed BESLER’s Revenue Integrity Solutions service...
Becerra Confirmation Boosts 22nd Century’s Position to Disrupt Tobacco Industry
Confirmation of Becerra as New HHS Secretary May Reignite FDA’s Plan to Eliminate Addictive CigarettesWILLIAMSVILLE, N.Y., March 19, 2021 (GLOBE...
Saniona Chairman J. Donald deBethizy and CEO Rami Levin, as well as additional members of the board and management, purchase Saniona shares in the open market
PRESS RELEASE March 19, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that...